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Central Role of IL-6 Receptor Signal-Transducing
Chain gp130 in Activation of L-Selectin Adhesion
by Fever-Range Thermal Stress
Jones and Rose-John, 2002). Through this mechanism,
macromolecular complexes containing IL-6 and a soluble
form of IL-6R (sIL-6R) found in serum and inflammatory
fluids initiate signaling through the transmembrane
gp130 signal-transducing chain (CD130). Engagement
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(i.e., IL-11, OSM, LIF) leads to the activation of JAK3 Department of Pathology and Preventive Medicine
tyrosine kinases and subsequent phosphorylation of ty-Roswell Park Cancer Institute
rosine residues within the gp130 cytoplasmic tail (Hein-Carlton and Elm Streets
rich et al., 2003). Four distal phosphotyrosine motifsBuffalo, New York 14263
recruit STAT3/1 (signal transducer and activator of tran-
scription) whereas phospho-Y759 interacts with SHP2
(SH2 domain-containing tyrosine phosphatase), trig-Summary
gering activation of the Ras/Raf/MEK/ERK (extracellular
signal-regulated protein kinase) pathway (Fukada et al.,The physiological benefit of the febrile response is
1996; Heinrich et al., 2003; Kim and Baumann, 1999).poorly understood. Here we show that fever-range
Recent studies suggest that the thermal componentthermal stress enhances the function of the L-selec-
of fever provides a “danger signal” to mobilize lympho-tin lymphocyte homing receptor through an interleu-
cytes to secondary lymphoid tissues during acute infec-kin-6 (IL-6)-dependent signaling mechanism. Thermal
tion or inflammation (Evans et al., 1999, 2000, 2001;stimulation of L-selectin adhesion in vitro and in vivo
Shah et al., 2002a; Wang et al., 1998). Multistep adhesiveis mediated by engagement of the gp130 signal-trans-
interactions are responsible for capturing circulatingducing chain by IL-6 and a soluble form of the IL-6
lymphocytes under hemodynamic shear and directingreceptor- (sIL-6R) binding subunit. Thermal control
extravasation across high endothelial venules (HEV) ofof adhesion is maintained in IL-6-deficient mice
lymph nodes (LN) and Peyer’s patches (PP) (Butcher etthrough a gp130-dependent compensatory mechanism
al., 1999). These include: (1) initial tethering and rollingmediated by IL-6-related cytokines (i.e., oncostatin M
on HEV mediated by lymphocyte L-selectin or 47 in-[OSM], leukemia inhibitory factor [LIF], and IL-11).
tegrin molecules, (2) G protein-dependent chemokineCombined biochemical and pharmacological inhibitor
activation of the 2 integrin, LFA-1, (3) LFA-1 and 47(PD98059, U0126, SB203580, SP600125) approaches
integrin-dependent firm adhesion to ICAM-1/2 or MAd-positioned MEK1/ERK1-2, but not p38 MAPK or JNK,
CAM-1, respectively, displayed on the lumenal surfacein the IL-6/sIL-6R signaling pathway upstream of
of HEV, and (4) transendothelial migration. Temperaturesactivation of L-selectin/cytoskeletal interactions and
that mimic febrile episodes (i.e., 38C–40C) amplify lym-L-selectin avidity/affinity. These results highlight a role
phocyte delivery across HEV through stimulation of ad-for gp130-linked IL-6/sIL-6R transsignaling in ampli-
hesion pathways in distinct cellular targets. Fever-rangefying lymphocyte trafficking during febrile inflamma-
temperatures act on lymphocytes in vitro and in vivo totory responses.
enhance both L-selectin and 47 integrin-dependent
homing to LN or PP (Wang et al., 1998; Evans et al.,Introduction
1999, 2000, 2001; Shah et al., 2002a). The binding activity
of gatekeeper HEV adhesion molecules including li-
Infection and tissue injury initiate highly integrated phys-
gands for L-selectin (i.e., PNAd and MAdCAM-1) and
iological responses directed toward protection of the
47 integrin (MAdCAM-1) is also augmented in vivo by
host. Although the evolutionarily conserved fever re- thermal stimuli initiated by whole body hyperthermia
sponse is closely linked to host survival (Kluger et al., (WBH) therapy or during LPS- or turpentine-induced in-
1998), it is the least understood component of the acute flammation (Evans et al., 2001).
inflammatory response with respect to its protective Fever-range temperatures enhance L-selectin avidity
mechanism of action. Endogenous pyrogens (i.e., in- and/or affinity without increasing the surface density,
terleukin-1 [IL-1], tumor necrosis factor- [TNF-], topographic localization on microvilli, or lectin binding
IL-6, interferons [IFN]-, -, and -, and prostaglandins) activity of this adhesion molecule (Evans et al., 1999,
released locally at sites of infection trigger the hypothal- 2000; Wang et al., 1998). The region of L-selectin re-
amus to induce systemic febrile responses. Studies in quired for the thermal response maps to the C-terminal
IL-6-deficient mice strongly implicate IL-6 as a critical 11 amino acids of the cytoplasmic tail (Evans et al., 1999,
mediator of IL-1- and TNF--induced fever (Leon, 2001). This cytoplasmic domain interacts constitutively
2002). with the cytoskeletal linker protein -actinin (Pavalko
IL-6 can have widespread effects, even in cells that et al., 1995). However, under normothermal conditions,
lack the membrane form of the ligand binding IL-6 recep- stable associations between L-selectin and the cy-
tor- (i.e., IL-6R/gp80, CD126) via a mechanism termed toskeletal matrix are only evident when L-selectin be-
transsignaling or receptor conversion (Hirano, 1999; comes engaged by physiologic ligands (GLYCAM-1) or
antibodies that mimic crosslinking by complex carbohy-
drate receptors (Evans et al., 1999; Leid et al., 2001).*Correspondence: sharon.evans@roswellpark.org
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Notably, fever-range thermal stress causes L-selectin to lymphocyte adhesion was enhanced by conditioned me-
dia from heat-treated hematopoietic cells and stromalpreassociate with the detergent-insoluble cytoskeletal
matrix (Evans et al., 1999). Stable associations with the cells (Table 1). In contrast, conditioned media derived
from hyperthermia-treated cells that represent paren-structural cytoskeletal scaffold are proposed to enhance
L-selectin tensile strength and thereby the efficiency chymal cells of various organs were universally incapa-
ble of stimulating lymphocyte-HEV interactions (Table 1).with which it withstands physiologic hemodynamic
shear within HEV. Conditioned medium from thermally activated human
PBL also induced L-selectin to become stably associ-The present study investigated the molecular mecha-
nisms underlying thermal regulation of L-selectin adhe- ated with the nonionic detergent-insoluble cytoskeletal
matrix, whereas L-selectin was highly susceptible tosion. Prior studies ruled out a direct thermal effect on
plasma membrane fluidity or L-selectin protein confor- extraction in cells maintained at normothermal tempera-
tures (Figure 1D). Similar increases in L-selectin adhe-mation (Shah et al., 2002a; Wang et al., 1998). Rather,
molecularly undefined factor(s) in the conditioned me- sion and L-selectin/cytoskeletal interactions occurred
in response to recombinant proinflammatory cytokinesdium of heat-treated lymphocytes actively stimulates
adhesion. This observation prompted the analysis of including IL-6, IFN-, IFN-, TNF-, and IL-1, whereas
IL-2 and IL-4 had no effect (Figure 1 and Table 2). Re-pyrogenic, proinflammatory cytokines in mediating ther-
mally induced changes in L-selectin adhesion. The pres- combinant IL-6 (Figure 1D), TNF-, IL-1, or IFNs (not
shown) did not affect L-selectin surface density, support-ent study identifies an autocrine and paracrine function
for IL-6, acting cooperatively with sIL-6R and mem- ing the conclusion that these factors control L-selectin
avidity and/or affinity. The L-selectin dependence of thebrane gp130, in amplifying L-selectin adhesion in re-
sponse to thermal stimulation in vitro and in vivo. These IL-6 response was confirmed using 300.19 murine B cells
stably expressing full-length human L-selectin (300.19/studies provide insight into a highly integrated cytokine
response initiated by febrile temperatures that promotes L-selectin) or a truncated form of L-selectin lacking the
C-terminal 11 amino acids (300.19/Lcyto) (see Supple-lymphocyte trafficking during inflammation.
mental Figure S1 at http://www.immunity.com/cgi/content/
full/20/1/59/DC1). The 3-fold increase in L-selectin-
specific adhesion detected in 300.19/L-selectin cellsResults
reflects a physiologically significant enhancement of
lymphocyte homing potential, as evidenced by a 4- toActivation of L-Selectin Adhesion by Fever-Range
Thermal Stress and Proinflammatory Cytokines 5-fold increase in L-selectin-dependent trafficking of
thermally treated 300.19/L-selectin cells to PLN tissuesTo examine the mechanisms underlying the increase in
L-selectin adhesion mediated by fever-range tempera- in vivo (Evans et al., 2001).
tures, we first compared the effect of thermal treatment
with a panel of recombinant proinflammatory cytokines. Neutralizing Antibodies to Endogenous IL-6 and IL-6
The time periods for treatments were chosen based on Receptor Components Inhibit Thermal Activation
previous findings that optimal stimulation of L-selectin of L-Selectin Adhesion
adhesion requires sustained exposure of lymphocytes Based on the similar activity of conditioned medium
to hyperthermia (6 hr) whereas conditioned medium from hyperthermia-treated cells and exogenous recom-
from heat-treated cells activates adhesion within 1–2 hr binant cytokines, we hypothesized that cytokines within
(Shah et al., 2002a; Wang et al., 1998). Treatment of the culture medium of heat-treated cells were respon-
human PBL with fever-range hyperthermia or condi- sible for mediating thermal responses. The flow cyto-
tioned medium from heat-treated lymphocytes signifi- metry-based multiplex soluble array technique de-
cantly increased lymphocyte adhesion under shear to monstrated the presence of several proinflammatory
postcapillary HEV in LN tissue cryosections when com- cytokines in human PBL-derived conditioned medium
pared with normothermal control conditions (Figures 1A although increases in cytokine concentrations were not
and 1B). Multiple lymphocyte subsets within human PBL detected in response to heat treatment. In a representa-
populations were responsive to thermal stress including tive experiment, the levels of cytokines (pM) in 37C
CD4 and CD8 T lymphocytes, CD19 B cells, CD56 and 40C conditioned medium, respectively, after 12 hr
NK cells, CD45RA naive lymphocyte subsets, and culture of human PBL (at 4  106 cells/ml) were 3.5 and
CD45RO memory cells (Figure 1C). The failure of heat 3.8 for IL-1, 61.2 and 55.3 for IL-1, 53.5 and 31.9 for
to stimulate adhesion in CD14 monocytes may relate IL-6, 7095 and 5873 for IL-8, and 3.8 and 3.5 for TNF-.
to observations that monocytes do not extravasate Other cytokines including IL-2, IL-3, IL-4, IL-10, IL-11,
across LN HEV under normal (i.e., noninflamed) condi- IL-12, IL-13, IL-15, IFN-, LIF, GM-CSF, TGF-1, and Flt-3
tions (Palframan et al., 2001). Thermally enhanced adhe- were not detected. These results raised the possibility
sion was shown to be L-selectin dependent using that thermal stress stimulates the bioactivity of selected
L-selectin-specific function-blocking mAb (DREG-56). cytokines without altering their apparent concentration.
Notably, thermal stimulation of adhesion occurred under To examine this question, human PBL were incubated
both serum-containing and serum-free conditions indi- at 40C in the presence of cytokine-neutralizing Ab and
cating that serum factors are not required (Figure 1A). then assessed for L-selectin-dependent adhesion to
Proadhesive effects were not unmasked by ex vivo heat PLN HEV and L-selectin/cytoskeletal interactions. Mini-
treatment of conditioned medium collected from PBL mal alterations of L-selectin adhesion (Figure 2A) or
cultured at 37C. A role for both autocrine- and para- L-selectin/cytoskeletal interactions (not shown) were
observed for lymphocytes treated in the presence ofcrine-derived factors was implicated by the findings that
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Figure 1. Fever-Range Temperatures and Recombinant IL-6 Stimulate L-Selectin Adhesion and L-Selectin/Cytoskeletal Interactions
(A–D) Human PBL were treated 6 hr at 37C or 40C (direct treatment), 2 hr at 37C with conditioned medium (C.M.) from control or heat-
treated PBL, or 2 hr with 10 ng/ml of rhIL-6. Cells were assayed for binding to HEV in murine LN cryosections under mechanical rotation. In
(C), the phenotype of adherent leukocytes was determined by prelabeling human PBL with mAb specific for leukocyte subsets followed by
RITC-labeled secondary Ab. Adhesion was assayed 	 L-selectin blocking mAb (DREG-56, 20 
g/ml). Dashed lines indicate basal level of
adhesion of normothermal controls. Photomicrographs show toluidine-stained human PBL (B) or RITC-labeled CD45RO cells (C) bound to
LN HEV. Bars, 20 
m. Data are the mean 	 SE of two to three experiments. The differences between adhesion of untreated cells and
hyperthermia/cytokine-treated cells were significant, p  0.0001 (*) or 0.001 (**), by unpaired two-tailed Student’s t test. (D) L-selectin levels
were detected by flow cytometry in nondetergent-treated cells (left panels) or following extraction in 0.5% NP-40 detergent (right panels).
Black histograms indicate staining with FITC-labeled L-selectin-specific mAb (anti-Leu-8); gray regions indicate background level of fluores-
cence detected with isotype-matched Ab. The frequency of L-selectin cells is shown.
neutralizing antibodies directed against IL-8, IFN-, uble IL-6R, and the membrane-associated gp130 sig-
nal-transducing molecule, in regulating proadhesiveIFN-, TNF-, or IL-1. However, neutralization of IL-6
markedly suppressed thermal activation of L-selectin thermal responses.
Multiple leukocyte subsets within human PBL popula-adhesion and L-selectin/cytoskeletal interactions (Fig-
ures 2A and 2B). Moreover, mAb-targeted inhibition of tions were shown to be a source of IL-6 although intra-
cellular IL-6 levels were consistently not augmented bythe individual IL-6 receptor components, i.e., IL-6R and
gp130, fully blocked adhesion in response to condi- fever-range thermal stress (Figure 2D). CD14 mono-
cytes produce high levels of IL-6 although this is a nu-tioned medium from heat-treated human PBL or recom-
binant IL-6 (Figure 2C). These data strongly implicate merically minor population in human PBL (i.e.,2%–10%
of total CD45 leukocytes). CD3CD4 and CD3CD8endogenous IL-6, acting through membrane and/or sol-
Immunity
62
Table 1. Leukocyte and Stromal-Derived Factors Stimulate L-Selectin Adhesion in Response to Fever-Range Temperaturea
Cell Type Cell Line 37C 	 SE 40C 	 SE
Hematopoietic 1 lymphocytes PBL 2.4 	 0.1 5.3 	 0.0*
T lymphocytes Molt-4 2.7 	 0.1 5.3 	 0.0*
CEM 2.7 	 0.1 5.2 	 0.1*
Jurkat 2.7 	 0.0 5.3 	 0.1*
B lymphocytes Daudi 2.6 	 0.1 5.1 	 0.1*
Raji 2.4 	 0.1 4.9 	 0.1*
Monocytes U937 2.5 	 0.1 4.9 	 0.1*
THP-1 2.5 	 0.1 5.3 	 0.1*
Stromal Endothelial cells HUVEC 2.9 	 0.1 6.0 	 0.1*
HMVEC 3.0 	 0.1 6.3 	 0.2*
Fibroblast cells NHDF 2.8 	 0.2 6.0 	 0.2*
Parenchymal Breast BT-20 2.1 	 0.1 2.2 	 0.0
Lung 9530 2.1 	 0.1 2.3 	 0.0
Melanocyte Colo-38 2.4 	 0.1 2.4 	 0.2
Hepatocyte HepG2 2.3 	 0.1 2.4 	 0.0
Neuroblast SK-N-MC 2.1 	 0.0 2.1 	 0.0
a Human PBL were cultured 2 hr at 37C in the presence of conditioned media from the indicated cell types (i.e., pretreated 12 hr at 37C or
40C). L-selectin-dependent adhesion of PBL to LN HEV was quantified in frozen-section assays under shear. Data are the mean 	 SE of 
three experiments. The differences between normothermal controls and hyperthermia treatments were determined to be significant, p 
0.0001 (*), by unpaired two-tailed Student’s t test.
T lymphocytes, CD19 B cells, and CD56CD16CD3 and 4.5 	 1.0 pM for sgp130, respectively; mean 	 SE
of three experiments). The failure of fever-range temper-NK cells synthesized relatively low levels of IL-6. How-
ever, since CD4 and CD8 T cells constitute the major atures to increase IL-6 secretion was confirmed using
a polyclonal Ab-based ELISA (Cytimmune) that recog-proportion of PBL (75% of total leukocytes), these
cells may contribute significantly to the pool of IL-6 nizes IL-6 within multimeric complexes (not shown).
Taken together, these data suggest that thermal stresspresent in conditioned medium. Standard mAb-based
ELISA analyses further showed that the detectable con- enhances the bioactivity or bioavailability of IL-6 without
increasing its synthesis or secretion. This conclusion iscentrations of IL-6, sIL-6R, or a soluble form of gp130
(sgp130) are not altered in PBL-derived conditioned me- supported by the finding that increases in IL-6-depen-
dent activity of heat-treated human PBL-conditioneddium by fever-range thermal stress (i.e., concentrations
in control and 12 hr heat-treated human PBL superna- medium were also detected in the highly sensitive B9
murine B cell hybridoma proliferation bioassay (Figuretants were 42.1 	 13.5 and 46.3 	 16.2 pM for IL-6,
6.7 	 0.8 and 5.5 	 1.4 pM for sIL-6R, and 4.5 	 0.8 2E) (Aarden et al., 1987).
Table 2. Fever-Range Temperature and Proinflammatory Cytokines Enhance L-Selectin Adhesion and L-Selectin/Cytoskeletal Associationa
Cells Bound/HEVb % Detergent-Insoluble
Untreated DREG-56 L-Selectinc
(A) Cell Incubation
37C 2.8 	 0.1* 1.4 	 0.1 1%
40C 5.2 	 0.1 1.4 	 0.1 63%
(B) Conditioned Medium
37C 3.0 	 0.1 1.4 	 0.1 0%
40C 5.7 	 0.2* 1.4 	 0.1 64%
(C) Recombinant Cytokines
IL-6 (10 ng/ml) 5.1 	 0.2* 1.3 	 0.2 64%
IFN- (500 IU/ml) 5.1 	 0.1* 1.3 	 0.1 67%
IFN- (500 IU/ml) 4.4 	 0.1* 1.3 	 0.1 61%
TNF- (100 IU/ml) 4.8 	 0.1* 1.3 	 0.1 64%
IL-1 (100 ng/ml) 4.6 	 0.1* 1.4 	 0.1 64%
IL-2 (100 IU/ml) 3.0 	 0.1 1.5 	 0.1 1%
IL-4 (5 ng/ml) 3.1 	 0.1 1.5 	 0.1 2%
a Human PBL were either (A) cultured continuously for 12 hr at 37C or 40C, (B) maintained for 2 hr at 37C in the presence of conditioned
medium derived from PBL pretreated at 37C or 40C (for 12 hr), or (C) cultured at 37C for 2 hr in the presence of recombinant cytokines.
b L-selectin-dependent adhesion of PBL to lymph node HEV was evaluated in frozen tissue-section adhesion assays under mechanical shear.
L-selectin-specific adhesion was assessed using DREG-56 blocking mAb. Data are the mean 	 SE of  three independent experiments.
Differences in adhesion of normothermal control and treated cells were significant, p  0.0001 (*), by unpaired two-tailed Student’s t test.
c The frequency of cells expressing L-selectin associated with the detergent-insoluble (0.5% NP-40) cytoskeletal matrix was assessed by flow
cytometry. Nondetergent-treated PBL were 69% L-selectin. Data are from one experiment and are representative of  three independent
studies.
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Figure 2. Endogenous IL-6 Mediates Fever-Range Thermal Activation of L-Selectin Adhesion and L-Selectin/Cytoskeletal Interactions
(A–C) Human PBL were pretreated 30 min with cytokine neutralizing Ab (5 
g/ml) and then cultured 6 hr at 37C or 40C. In (A) and (C),
adhesion to LN HEV was quantified in frozen-section adhesion assays. Data are the mean 	 SE of three experiments. The differences between
untreated and Ab-treated cells were significant, p  0.0001 (*), by unpaired two-tailed Student’s t test. In (A), the dashed line indicates the
basal level of adhesion of normothermal controls. In (B), human PBL were extracted in 0.5% NP-40, followed by staining with FITC-labeled
L-selectin mAb (anti-Leu-8). Gray regions indicate background fluorescence of cells stained with isotype-matched Ab. The frequency of cells
with L-selectin associated with the detergent-insoluble matrix is shown.
(D) Human PBL were incubated for 12 hr at 37C or 40C in the presence of brefeldin A and stained with fluorochrome-labeled mAb specific
for leukocyte antigens and PE-anti-IL-6 mAb (black histograms). Gray histograms indicate the level of fluorescence detected with PE-labeled
isotype-matched Ab. The frequency of cells expressing intracellular IL-6 and the MCF (mean channel fluorescence) is shown.
(E) [3H]thymidine incorporation was measured in B9 cells after incubation for 72 hr at 37C with rhIL-6 (10 pg/ml) or human PBL conditioned
medium (1:50 dilution; from control or 6 hr heat-treated cultures; p  0.02 [*]). Anti-human IL-6 mAb (20 
g/ml) reduced [3H]thymidine
incorporation to 300–1000 CPM in all conditions. Data are representative of  three experiments.
Role of gp130-Linked IL-6/sIL-6R Transsignaling IL-6/sIL-6R transsignaling through its ability to prefer-
entially interact with soluble IL-6/sIL-6R complexes butfor Thermal Stimulation of L-Selectin Adhesion
In Vitro and In Vivo is essentially ineffective in blocking signaling via mem-
brane-bound IL-6R (Jostock et al., 2001; Muller-NewenFlow cytometric analyses indicated that expression of
membrane IL-6R was below the level of detection on et al., 1998; Narazaki et al., 1993). sgp130 prevented
activation of adhesion when included in human PBLnontreated or hyperthermia-treated human PBL (data
not shown). Limited expression of membrane IL-6R cultures during direct thermal stimulation (Figure 3A). It
also repressed the activity of 40C conditioned mediumsuggested that primary human lymphocytes might be
regulated by sIL-6R present in the conditioned medium or recombinant IL-6 (Figures 3A and 3B), implicating an
appreciable contribution of IL-6/sIL-6R transsignalingvia a transsignaling mechanism. To assess the contribu-
tion of sIL-6R to thermal regulation of adhesion, human to the effector phase of thermal stimulation of adhesion.
Analysis of the role of IL-6 as part of IL-6/sIL-6RPBL were stimulated with fever-range hyperthermia in
the presence of recombinant sgp130 prior to the analy- complexes in stimulating L-selectin adhesion was ex-
tended to murine splenocytes isolated from C57BL/6sis of L-selectin binding activity (Figure 3A). Naturally
occurring sgp130 has competitive inhibitor activity for wild-type mice and IL-6-deficient mice (Figure 3C). Fe-
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Figure 3. IL6/sIL-6R Transsignaling Is Required for Fever-Range Thermal Stimulation of L-Selectin Adhesion In Vitro and In Vivo
rhsgp130 (20 ng/ml) or cytokine-neutralizing mAb (5 
g/ml) were added to human PBL (A and B) or mouse splenocytes from wild-type or
IL-6/ mice (C) 30 min prior to culture for 6 hr at 37C or 40C (direct hyperthermia treatment, HT) or treatment for 2 hr at 37C with rhIL-6
or conditioned medium from control and heat-treated human PBL. Adhesion to HEV of LN cryosections was assessed under shear. In (B),
SE for all data were 0.2; equivalent increases in adhesion were detected with rIL-6 (5 ng/ml) and 40C treatment (4.13  0.03 cells bound/
HEV). (D) BALB/c mice were injected with isotype control Ab (MOPC-104), anti-mouse IL-6 neutralizing mAb (100 
g/mouse), or rhsgp130 (2.5

g/mouse) 30 min prior to WBH treatment for 6 hr. Isolated splenocytes were evaluated for adhesion to LN HEV with or without Mel-14
blocking mAb. Photomicrographs show HEV structures containing adherent cells. Bars, 20 
m. Dashed lines represent basal level of adhesion
of normothermal controls; data are the mean 	 SE of three experiments. Differences between control and treatment groups were significant,
p  0.0005 (*), by unpaired two-tailed Student’s t test.
ver-range hyperthermia treatment in vitro of splenocytes gated by recombinant sgp130. Prior studies established
that sgp130 competitively inhibits signaling by IL-6 fam-from IL-6/ mice significantly increased their adhesion
to LN HEV under shear. The thermal effects were ily cytokines by interacting with cytokine/soluble recep-
tor complexes (i.e., IL-6R, IL-11R, LIFR) or directblocked by anti-mouse L-selectin mAb (i.e., Mel-14) and
by IL-6 neutralizing mAb, while anti-IL-1 and TNF- binding to OSM (Jones and Rose-John, 2002). There-
fore, contributions of IL-6-related cytokines were inves-mAb were ineffective. Recombinant sgp130 fully inhib-
ited thermal stimulation of adhesion in IL-6/ mice tigated. The thermal response in IL-6-deficient mice was
partially inhibited by IL-11-, LIF-, and OSM-specific mAbwhereas mAb targeting of other IL-6 family cytokines
had no effect. while combined targeting of these cytokines fully
blocked thermal stimulation (Figure 3C). Taken together,Remarkably, the thermal response was fully main-
tained in splenocytes from IL-6/ mice although, as these data confirm that signaling via membrane gp130
is pivotal in controlling L-selectin adhesion in responseexpected, this adhesion was not influenced by IL-6 neu-
tralizing mAb (Figure 3C). Neutralizing mAb against IL- to thermal stress in vitro.
To determine whether similar gp130-dependent mecha-1 and TNF- did not prevent thermal stimulation of
adhesion. However, hyperthermia-enhanced adhesion nisms regulate L-selectin adhesion in vivo, BALB/c mice
were treated for 6 hr with WBH to raise the core bodyof splenocytes from IL-6/ mice was completely abro-
Thermal Control of L-Selectin Adhesion by IL-6
65
temperature to a febrile range (39.8C 	 0.2C) (Evans inhibitors prevented activation of adhesion by recombi-
nant IL-6 (Figure 4D) as well as by conditioned mediumet al., 2001). Systemic levels of IL-6 were not affected
by this treatment (i.e., concentrations in control and from heat-treated human PBL (Figure 4F), strongly impli-
cating the MEK1/ERK1-2 pathway in the effector phaseWBH-treated mice were 4 pg/ml; n  6 mice). Prior to
treatment, control (36.8C 	 0.2C) and WBH-treated of thermal stimulation of L-selectin adhesion.
mice were injected with isotype-matched control mAb,
neutralizing anti-mouse IL-6 mAb, or recombinant Discussion
sgp130. Both IL-6 neutralizing mAb and recombinant
sgp130 fully repressed thermal activation of L-selectin The present study identifies a mechanism whereby fe-
adhesion in splenocytes isolated from WBH-treated ver-range thermal stress augments L-selectin-depen-
mice (Figure 3D). These data suggest that IL-6/sIL-6R dent lymphocyte homing potential through an IL-6-
transsignaling largely accounts for thermal activation of mediated signaling pathway. These findings provide an
L-selectin adhesion in vivo. A role for membrane IL- explanation for the physiological benefit of the phyloge-
6R signaling is suggested by evidence that constitutive netically conserved fever response that accompanies
adhesion is suppressed by IL-6 neutralizing mAb but infection and inflammation. Since L-selectin is a major
not by sgp130 in vivo. homing receptor required for efficient emigration of na-
ive lymphocytes into LN and PP, and leukocytes at extra-
lymphoid sites of inflammation (Butcher et al., 1999), aMEK1/ERK1-2, but Not p38 MAPK or JNK, Mediate
Thermal Stimulation of L-Selectin Adhesion physiological consequence of thermal stress would be
to enhance immune surveillance by increasing the op-Multiple intracellular signal transduction pathways are
activated by stress and proinflammatory cytokines. IL-6 portunity for leukocytes to encounter foreign pathogens
in peripheral tissues. The finding that heat augmentsengagement of membrane-associated gp130 activates
STAT3/STAT1 and MEK1/ERK1-2 signaling cascades L-selectin binding of CD45RO lymphocytes suggests
that the thermal element of fever amplifies the magni-(Heinrich et al., 2003). In some cellular systems, the
stress kinases, p38 MAPK and JNK, are also activated tude of the immune response by mobilizing central mem-
ory cells (Sallusto et al., 2000) to LN and PP. Our studiesby IL-6 or heat shock (e.g., 42C) (Xu et al., 1998;
Yujiri et al., 1998; Zauberman et al., 1999). Combined indicate that control of L-selectin binding function by
fever-range thermal stress is an exquisitely regulatedbiochemical and pharmacological approaches were
used to identify the signaling pathways underlying fever- event. Lymphocyte adhesion depends not only on IL-6,
but also on a soluble form of the IL-6R. Together theserange thermal activation of L-selectin adhesion.
Thermal treatment of human PBL resulted in progres- molecules function as a heterodimeric cytokine where
both components are required to deliver a biologicalsive and sustained activation of phospho-ERK1-2, as
determined by Western blot analysis (Figure 4A). Nota- effect. This mechanism of action was revealed opera-
tionally by the finding that recombinant sgp130, a com-bly, the kinetics of ERK1-2 activation paralleled the time
course required for optimal stimulation of L-selectin ad- petitive inhibitor of transsignaling via sIL-6R (Jones
and Rose-John, 2002; Jostock et al., 2001; Muller-hesion (Wang et al., 1998). The moderate level of ERK1-2
activation detected in response to thermal stimulation Newen et al., 1998; Narazaki et al., 1993), prevents ther-
mal activation of L-selectin adhesion in vitro and in vivo.is distinguished from the potent but transient activation
induced by the pharmacologic agent, PMA (Figure 4A). Observations that IL-6/sIL-6R mediate thermal effects
on adhesion in species that diverged 180 million yearsThermal activation of ERK1-2 depended on IL-6 activity
(neutralized by anti-IL-6 mAb) and IL-6/sIL-6R transsig- ago (i.e., mouse and human) (Simpson, 1959) indicate
that this cytokine response, like fever, is evolutionarilynaling (neutralized by recombinant sgp130) (Figure 4A).
gp130-dependent activation of STAT3 also occurred in conserved.
These findings support a role of IL-6/sIL-6R in theresponse to fever-range thermal stimulation (Figure 4B).
In contrast, thermal stress failed to activate phospho- regulation of acute and chronic inflammatory responses
(Jones and Rose-John, 2002). IL-6/sIL-6R has beenp38 MAPK or JNK over a 6 hr time interval (Figure 4C).
Moreover, thermal activation of adhesion was not af- implicated in maintaining the survival of T lymphocytes
at sites of chronic inflammation through STAT3-depen-fected by pharmacologic inhibitors of p38 MAPK
(SB203580) or JNK (SP600125) (Figure 4D) at concentra- dent upregulation of the antiapoptotic proteins bcl-2 and
bclXL (Atreya et al., 2000). IL-6/sIL-6R also orchestratestions that selectively target these enzymes without af-
fecting ERK1-2 activity in leukocytes (Bennett et al., recruitment of leukocytes to inflammatory lesions in ex-
perimental murine models for colonic inflammation, re-2001; Dean et al., 1999).
Thermal stimulation of L-selectin adhesion and nal cell failure, or bacterial infection (Atreya et al., 2000;
Hurst et al., 2001; Jones and Rose-John, 2002; RomanoL-selectin/cytoskeletal interactions was fully blocked by
PD98059 (Figures 4D and 4E). At the concentration used, et al., 1997). Leukocyte recruitment has principally been
attributed to local effects on vascular adhesion withinPD98059 inhibits phosphorylation of MEK1 and its
downstream targets (i.e., ERK1-2) but not JNK or p38 tissue microenvironments based on evidence that IL-6/
sIL-6R transsignaling stimulates expression of adhe-MAPK (Alessi et al., 1995). Similar effects were observed
with U0126 (Figure 4D), which inhibits MEK1 enzymatic sion molecules (ICAM-1, VCAM-1) and chemokines
(MCP-1, MCP-3, IL-8) in cultured endothelial cells andactivity through a nonoverlapping mechanism (Favata
et al., 1998). These inhibitors did not affect basal levels mesothelial cells in vitro and chemokine (MCP-1) pro-
duction in vivo (Hurst et al., 2001; Jones and Rose-John,of L-selectin adhesion (Figure 4D), L-selectin expression
(Figure 4E), or lymphocyte viability (not shown). MEK1 2002; Modur et al., 1997; Romano et al., 1997). The
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Figure 4. Requirement for MEK1/ERK1-2 Activation for IL-6 Stimulation of L-Selectin Adhesion during Fever-Range Thermal Responses
(A–C) Following stimulation by fever-range hyperthermia or PMA (1 nM), human PBL were analyzed by Western blotting for phospho- or total
ERK1-2, STAT3, p38 MAPK, or JNK. Unless otherwise indicated, thermal treatments were performed under serum-free conditions to reduce
basal levels of activated signaling molecules; note that the basal level of phospho-ERK was variable among PBL populations from different
donors. IL-6 neutralizing mAb (5 
g/ml), rhsgp130 (10 ng/ml), or anti-human gp130 neutralizing mAb (5 
g/ml) were added to selected cultures
30 min prior to thermal stimulation. In (C), equivalent protein concentrations of lysate from SK-MEL-28 cells treated with an apoptotic agent
were used as a standard for phospho-p38 MAPK and JNK.
(D–F) Human PBL were treated for 30 min at 37C with PD98059 (PD), U0126 (U), SB203580 (SB), SP600125 (SP), or DMSO vehicle control
(V); (C) is untreated control. Cells were then cultured 6 hr at 37C or 40C or for 2 hr at 37C with rIL-6 (10 ng/ml) or conditioned medium from
control and heat-treated PBL. Assays for adhesion and detergent-insoluble L-selectin were performed as in Figure 1. Dashed lines indicate
basal level of adhesion of normothermal control. Data are the mean 	 SE of triplicate samples and represent  three experiments; differences
between normothermal controls and treatment groups were significant, p  0.0001 (*) or 0.005 (**), by unpaired two-tailed Student’s t test.
current study enlarges on this view by demonstrating the requirement for IL-6 during thermal activation of
adhesion. However, results demonstrating a role for athat lymphocytes are also a target for IL-6/sIL-6R with
regard to promoting adhesion. The experimental appli- wide panel of recombinant proinflammatory cytokines
(i.e., IL-6/sIL-6R, TNF-, IL-1, IFN-, and IFN-) incation of heat in vitro or in vivo allowed us to identify
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regulating L-selectin function in vitro raise the possibility The present study positions ERK1-2 in a signaling
pathway linking cytokine-initiated extracellular responsesthat multiple cytokines participate in amplifying lympho-
cyte homing during the physiological setting of infection to activation of L-selectin adhesion. These results are of
interest in light of more established evidence thatand natural fever.
Several major findings distinguish thermal regulation ERK1-2 activation occurs primarily as a downstream
consequence of adhesion (Giancotti and Ruoslahti,of IL-6/sIL-6R bioactivity from what has been reported
for control of IL-6 transsignaling during infection or in- 1999). A notable finding is that thermal stress activates
only a subfraction of ERK in lymphocytes as comparedflammation. In patients with pathologic inflammatory
disorders or in experimental animal models for infection with the maximal stimulation achieved with PMA. Re-
stricted local ERK activation within a specific subcellularor inflammatory disease, increased IL-6 bioactivity is
associated with elevated local or systemic concentra- microdomain may direct ERK1-2 toward appropriate tar-
gets that stabilize interactions between the -actinintions of IL-6 and/or sIL-6R (Jones and Rose-John,
2002). This is in contrast to results reported here where binding element within the L-selectin cytoplasmic tail
(Pavalko et al., 1995) and the actin-based structural cy-fever-range thermal stress increases the bioactivity or
bioavailability of IL-6 (i.e., detected in bioassays for lym- toskeleton (Evans et al., 1999; Leid et al., 2001). An
important question for future investigation is whetherphocyte adhesion or B9 proliferation) without changing
the apparent concentrations of IL-6, sIL-6R, or sgp130. STAT3 is required to integrate ERK1-2-dependent regu-
lation of adhesion in response to fever-range thermalThus, the increase in the proadhesive activity of IL-6 is
not the result of an imbalance in the molar concentra- stress.
The mechanisms underlying thermal regulation of IL-6tions of IL-6, sIL-6R (agonist), or sgp130 (antagonist).
An interesting question raised by our findings is how bioactivity and/or bioavailability warrant further study.
Factor(s) released by hematopoietic cells or stromalrecombinant IL-6 (400 pM) transduces signals via the
limited amounts of sIL-6R (6 pM) detected in condi- cells in response to thermal stress could theoretically
stabilize interactions between IL-6 and sIL-6R or physi-tioned medium. One explanation is that the relatively
low-affinity IL-6R (KD 1000 pM) (Hibi et al., 1990) is cally impede binding with the natural antagonist,
sgp130, at physiologic concentrations. Either of theselikely to be minimally occupied by leukocyte-derived
IL-6 in culture medium. In this regard, endogenous IL-6 scenarios could result in an increase in the affinity of
IL-6/sIL-6R for transmembrane gp130. Precedent forconcentrations (40 pM) are well below the IL-6R KD
value. Thus, sIL-6R molecules would be available for this line of reasoning is provided by studies demonstra-
ting an increase in circulating IL-6 bioactivity, but not inbinding to recombinant IL-6 and subsequent high-affin-
ity interactions with membrane gp130 (KD 50 pM) (Hibi total IL-6 serum concentrations detected by commercial
mAb-based ELISA, in patients undergoing anticanceret al., 1990), resulting in activation of adhesion in a dose-
dependent manner characteristic for ligand/receptor re- therapy with autotolgous tumor preparations (Ndubuisi
et al., 1998; Sehgal, 1996). In those studies, unique,sponses. Another possibility is that the biological activity
of endogenous IL-6 or the IL-6/sIL-6R complex is epitope-specific anti-IL-6 mAb suggested that un-
masking or conformational changes in IL-6 accompanymasked by factors in normothermal cell cultures such
that it is less effective than recombinant IL-6 in signaling increases in IL-6 bioactivity detected in B9 hybridoma
growth assays and Hep3B hepatocyte stimulationthrough membrane gp130.
Thermal activation of L-selectin adhesion was unex- assays. Alternatively, heat-induced factor(s) could lower
the threshold of lymphocyte responses to endogenouspectedly found to be maintained in IL-6-deficient mice
through a membrane gp130-dependent mechanism. IL-6/sIL-6R without influencing molecular interactions
within this multimeric complex. Notably, heat shock pro-This is in contrast to observations in experimental mod-
els of infection or inflammation where defects have been tein-90 (HSP90) has been shown to physically associate
with STAT3 and Raf-1 under normothermal or fever-reported in IL-6/ mice with regard to local neutrophil
recruitment and chemokine production, liver regenera- range conditions while disruption of these interactions
by the HSP90-specific inhibitor geldanomycin severelytion, cutaneous wound healing, and posttraumatic tis-
sue repair in the central nervous system (Cressman et compromises Raf-1/MEK1/ERK1-2 signal transduction
or IL-6-mediated STAT3 transcriptional responsesal., 1996; Gallucci et al., 2000; Hurst et al., 2001; Romano
et al., 1997; Swartz et al., 2001). Although IL-6/ mice (Schulte et al., 1995; Shah et al., 2002b).
Our studies support a two-stage model (Figure 5) inreportedly exhibit increased expression of TNF- (Xing
et al., 1998), this proinflammatory cytokine does not which thermal stress accompanying infection, inflam-
mation, or clinical hyperthermia therapy initially providescompensate for the loss of IL-6 in thermal regulation of
L-selectin adhesion. The ability of IL-6-deficient mice to a danger signal, resulting in an increase in the bioactivity
of autocrine or paracrine IL-6/sIL-6R. Thermally acti-develop compensatory mechanisms that substitute for
IL-6 during thermal responses may be an indicator of vated IL-6/sIL-6R complexes then act on lymphocytes
in the effector phase to stimulate L-selectin/cytoskeletalthe evolutionary importance of maintaining gp130-
dependent signaling events for protection of the host interactions and thereby L-selectin adhesion via an in-
side-out-signaling mechanism involving ERK1-2. Exqui-against pathogenic challenges. Notably, contributions
of other gp130-dependent IL-6 family cytokines (OSM, site control of IL-6 bioactivity through interactions with
sIL-6R may be a means of physiologically regulatingLIF, IL-11) in regulating L-selectin adhesion were only
revealed in IL-6/mice where immune systems develop adhesion in specific cellular targets that express limited
transmembrane IL-6R (i.e., lymphocytes) without in-without IL-6. Similar cytokine redundancy has been re-
ported in IL-6/ mice for febrile responses induced by ducing pathologic side effects in other cell types (e.g.,
hepatocytes) that are less susceptible to IL-6/sIL-6Rhigh doses of LPS (Leon, 2002).
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Figure 5. Model for Role of IL-6/sIL-6R
Transsignaling in Mediating Thermal Activa-
tion of L-Selectin Adhesion
Fever-range temperatures increase L-selec-
tin-dependent homing of lymphocytes by
enhancing the bioactivity or bioavailability of
IL-6/sIL-6R. HT, hyperthermia.
Cytokine Assaystranssignaling because of constitutive expression of
mAb (R&D Systems) and polyclonal Ab (Cytimmune, College Park,membrane IL-6R (Heinrich et al., 2003; Jones and
MD) ELISA assays for hIL-6, hsIL-6R, hsgp130, or mIL-6 wereRose-John, 2002). Collectively, these results provide in-
performed. Cytokines were also evaluated using a multiplex mi-
sight into the complex, highly integrated mechanisms crosphere assay (Luminex Inc., Austin, TX) (detection limit, 1 pM)
whereby fever-range temperatures amplify immune pro- (Shah et al., 2002a).
tection during infection or inflammatory responses.
Flow Cytometric Analysis of L-Selectin/Cytoskeletal
Experimental Procedures
Association and Intracellular IL-6
L-selectin cell surface expression (i.e., without detergent) and
Cell Cultures
L-selectin interactions with the detergent-insoluble cytoskeletal ma-
Adherence-depleted human PBL (American Red Cross, Rochester,
trix were assessed as described (Evans et al., 1999). Following ex-
NY) and mouse splenocytes (BALB/c [Taconics, Germantown, NY],
traction of 2  106 human PBL (0.5% NP-40, 50 mM NaCl, 2 mM
wild-type C57BL/6 mice, or IL-6-deficient mice [Jackson Labs, Bar
MgCl2, 0.22 mM EGTA, 13 mM Tris [pH 8.0], 1 mM PMSF, 2% FCS),Harbor, ME]) were cultured at 4 106 cells/ml in RPMI-1640 medium
detergent-insoluble fractions were stained with FITC-anti-L-selectinwith 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, and 50 
g/ml
mAb. Fluorescence associated with a lymphocyte gate (excludingstreptomycin (GIBCO BRL, Grand Island, NY) (Evans et al., 2001).
monocytes and neutrophils; 5000 events) was analyzed on a FACS-Mouse pre-B 300.19/L-selectin or 300.19/Lcyto cells (Evans et al.,
can (BD Biosciences, San Jose, CA) using Winlist 4.0 (Verity Soft-1999), the human Burkitt’s B lymphoma Daudi C11 clone (Evans et
ware House, Inc., Topsham, ME).al., 1993), and HepG2 human hepatocyte cells (Kim and Baumann,
Multiparameter flow cytometric analysis was used to determine1999) were described previously. Human primary endothelial cells
the intracellular expression of IL-6 in phenotypically defined leuko-(HUVEC, HMVEC) and dermal fibroblasts were from Clonetics (Walk-
cyte subsets cultured with brefeldin A (20 
M, Sigma) and stainedersville, MD). Human T cell lines (Jurkat, Molt-4, and CEM), U937
with PE-anti-IL-6 mAb and fluorochrome-labeled leukocyte-specificpremyeloid cell line (Dr. P. Aplan, National Cancer Institute,
mAb (Stewart and Stewart, 2001). The specificity of IL-6 stainingBethesda, MD); Raji B cells, THP-1 monocytic cells, BT20-p4 breast
was confirmed by blocking PE-anti-IL-6 mAb with a 2-fold molarcarcinoma, neuroblastoma SK-N-MC cells, 9530 lung cells (Dr. T.B.
excess of rhIL-6. Data were collected uncompensated on a BDTomasi, Roswell Park Cancer Institute, Buffalo, NY); Colo-38 mela-
FACSAria (BD Biosciences), and compensation was adjusted in Win-noma cells (Dr. S. Ferrone, Roswell Park Cancer Institute); and B9
list using single-color stained samples.murine B cell hybridoma (Dr. J. Gauldie, McMaster University, Hamil-
ton, Canada) were used. Cell viability was 95% as determined by
trypan blue exclusion and TUNEL assay (Shah et al., 2002a). Frozen-Section Adhesion Assay
Lymphocyte adhesion to HEV in 12 
m PLN cryosections of BALB/c
Cytokines, mAb, Reagents mice was evaluated under mechanical rotation as described (Evans
Recombinant human [rh] IL-2, IL-4, IL-6, TNF-, sgp130, mouse [m] et al., 2001). Human and mouse L-selectins are highly homologous;
IL-6 (R&D Systems, Minneapolis, MN); rhIL-1, rhIFN- (Genzyme, thus, the binding function of human L-selectin can be assayed on
Cambridge MA); and rhIFN- (Schering Corp., Bloomfield, NJ) were PNAd ligands expressed in mouse LN HEV (Kishimoto et al., 1990).
used. Equivalent results were obtained using rhIL-6 produced in Cos Lymphocyte adhesion was quantified by light microscopy (Olympus,
cells (Genetics Institute, Cambridge, MA). The endotoxin inhibitor Spectra Services Inc., Webser, NY) in a total of 300–500 HEV in each
polymixin B (0.1 
g/ml, Calbiochem, San Diego, CA) had no effect toluidine-stained section. For consistency in double-blind evalua-
on recombinant cytokine responses. Mouse mAb or rabbit poly- tion of large numbers of replicate samples, HEV were quantified
clonal Ab to human or mouse cytokines, IL-6R, or gp130 were from only if they contained 1 adherent cell. The phenotype of adherent
R&D Systems, Genzyme, or Interferon Sciences (New Brunswick, human leukocyte subsets was determined by labeling cells with
NJ). mAb to mL-selectin [Mel-14] and hL-selectin [DREG-56] were mAb specific for leukocyte antigens and RITC-goat anti-mouse IgG
from American Type Culture Collection (ATCC, Rockville, MD). Fluo- prior to the frozen-section assay (Frey et al., 1998). The number of
rochrome-labeled mAb specific for hL-selectin [Leu-8] or leukocyte fluorescent cells bound per HEV was quantified on an Olympus
antigens were from BD (Franklin Lakes, NJ), Caltag (Burlingame, BH2/RFL fluorescence microscope (Olympus Optical, Tokyo,
CA), or Beckman Coulter (Fullerton, CA). PE-anti-hIL-6 was from Japan).
R&D Systems. RITC-labeled goat anti-mouse IgG was from Southern
Biotech. (Birmingham, AL). PMA (Sigma Chemical Corp., St Louis,
B9 Hybridoma Proliferation AssayMO), U0126, PD98059, SB203580 (Calbiochem), and SP600125 (A.G.
B9 cells were resuspended in IL-6-free medium and plated in tripli-Scientific Inc., San Diego, CA) were purchased.
cate at 2.5 104 cells per well in 96-well plates with rhIL-6 or human
PBL-derived conditioned medium 	 anti-human IL-6 mAb. AfterFever-Range Thermal Treatment
culture for 67 hr, cells were pulsed with [3H]thymidine (1 
Ci/well;Cells were cultured at 40C in a 5% CO2 incubator; fever-range WBH
PerkinElmer [Wellesley, MA]) for 5 hr and counted in a 1450 Mi-treatment of BALB/c mice (core temperature of 39.8C 	 0.2C for
6 hr) was as described (Evans et al., 2001). croBeta counter (Trilux, Germany).
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SDS-PAGE and Western Blotting Evans, S.S., Bain, M.D., and Wang, W.C. (2000). Fever-range hyper-
thermia stimulates alpha4beta7 integrin-dependent lymphocyte-Human PBL were resuspended in serum-free medium prior to stimu-
lation by fever-range hyperthermia or PMA (1 nM, Sigma). A total endothelial adhesion. Int. J. Hyperthermia 16, 45–59.
of 1–107 PBL were lysed on ice in RIPA buffer (50 mM Tris [pH 7.4], Evans, S.S., Wang, W.C., Bain, M.D., Burd, R., Ostberg, J.R., and
1% NP40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, Repasky, E.A. (2001). Fever-range hyperthermia dynamically regu-
1 
g/ml aprotinin, 1 
g/ml leupeptin, 1 mM sodium vanadate, and lates lymphocyte delivery to high endothelial venules. Blood 97,
0.1 mM PMSF). Equal amounts of protein (50 
g) were fractionated 2727–2733.
on reducing SDS gels (10% acrylamide) and analyzed by Western
Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J., Stradley,
blotting with commercial antibodies specific for total or phospho-
D.A., Feeser, W.S., Van Dyk, D.E., Pitts, W.J., Earl, R.A., Hobbs, F.,
proteins (Cell Signaling, Beverly, MA) (Kim and Baumann, 1999).
et al. (1998). Identification of a novel inhibitor of mitogen-activated
Lysates from SK-MEL-28 cells (Chen et al., 2003) (Dr. Y. Chen, Ros-
protein kinase kinase. J. Biol. Chem. 273, 18623–18632.
well Park Cancer Institute) were used as standards for phosphory-
Frey, M., Packianathan, N.B., Fehniger, T.A., Ross, M.E., Wang,lated p38 MAPK and JNK.
W.C., Stewart, C.C., Caligiuri, M.A., and Evans, S.S. (1998). Differen-
tial expression and function of L-selectin on CD56bright andAcknowledgments
CD56dim natural killer cell subsets. J. Immunol. 161, 400–408.
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